Cardiac Tissue Engineering for the Treatment of Myocardial Infarction

Poor cell engraftment rate is one of the primary factors limiting the effectiveness of cell transfer therapy for cardiac repair. Recent studies have shown that the combination of cell-based therapy and tissue engineering technology can improve stem cell engraftment and promote the therapeutic effect...

Full description

Bibliographic Details
Main Authors: Dongmin Yu, Xiaowei Wang, Lei Ye
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
Online Access:https://www.mdpi.com/2308-3425/8/11/153
_version_ 1797509935935782912
author Dongmin Yu
Xiaowei Wang
Lei Ye
author_facet Dongmin Yu
Xiaowei Wang
Lei Ye
author_sort Dongmin Yu
collection DOAJ
description Poor cell engraftment rate is one of the primary factors limiting the effectiveness of cell transfer therapy for cardiac repair. Recent studies have shown that the combination of cell-based therapy and tissue engineering technology can improve stem cell engraftment and promote the therapeutic effects of the treatment for myocardial infarction. This mini-review summarizes the recent progress in cardiac tissue engineering of cardiovascular cells from differentiated human pluripotent stem cells (PSCs), highlights their therapeutic applications for the treatment of myocardial infarction, and discusses the present challenges of cardiac tissue engineering and possible future directions from a clinical perspective.
first_indexed 2024-03-10T05:24:46Z
format Article
id doaj.art-789e67006a51439197bab40a44cbbfa8
institution Directory Open Access Journal
issn 2308-3425
language English
last_indexed 2024-03-10T05:24:46Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Journal of Cardiovascular Development and Disease
spelling doaj.art-789e67006a51439197bab40a44cbbfa82023-11-22T23:47:59ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252021-11-0181115310.3390/jcdd8110153Cardiac Tissue Engineering for the Treatment of Myocardial InfarctionDongmin Yu0Xiaowei Wang1Lei Ye2Department of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, ChinaDepartment of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, ChinaNational Heart Research Institute Singapore, National Heart Centre Singapore, 5 Hospital Drive, Singapore 169609, SingaporePoor cell engraftment rate is one of the primary factors limiting the effectiveness of cell transfer therapy for cardiac repair. Recent studies have shown that the combination of cell-based therapy and tissue engineering technology can improve stem cell engraftment and promote the therapeutic effects of the treatment for myocardial infarction. This mini-review summarizes the recent progress in cardiac tissue engineering of cardiovascular cells from differentiated human pluripotent stem cells (PSCs), highlights their therapeutic applications for the treatment of myocardial infarction, and discusses the present challenges of cardiac tissue engineering and possible future directions from a clinical perspective.https://www.mdpi.com/2308-3425/8/11/153engineered cardiac tissuemyocardial infarctionstem cells
spellingShingle Dongmin Yu
Xiaowei Wang
Lei Ye
Cardiac Tissue Engineering for the Treatment of Myocardial Infarction
Journal of Cardiovascular Development and Disease
engineered cardiac tissue
myocardial infarction
stem cells
title Cardiac Tissue Engineering for the Treatment of Myocardial Infarction
title_full Cardiac Tissue Engineering for the Treatment of Myocardial Infarction
title_fullStr Cardiac Tissue Engineering for the Treatment of Myocardial Infarction
title_full_unstemmed Cardiac Tissue Engineering for the Treatment of Myocardial Infarction
title_short Cardiac Tissue Engineering for the Treatment of Myocardial Infarction
title_sort cardiac tissue engineering for the treatment of myocardial infarction
topic engineered cardiac tissue
myocardial infarction
stem cells
url https://www.mdpi.com/2308-3425/8/11/153
work_keys_str_mv AT dongminyu cardiactissueengineeringforthetreatmentofmyocardialinfarction
AT xiaoweiwang cardiactissueengineeringforthetreatmentofmyocardialinfarction
AT leiye cardiactissueengineeringforthetreatmentofmyocardialinfarction